Over its four years of research, the GLINT project will achieve a
number of key results on its path to providing a wide-ranging new diagnostic tool. The list below
contains the project's public deliverables.
Name | Date | Link |
---|---|---|
GLINT Report Summary (2nd Reporting Period) | 2019-04-16 | https://cordis.europa.eu/project/id/667510/reporting |
Development and implementation of optimized MRI CEST sequences based, e.g. on SSFP | 2019-03-28 | D2.4 Development and implementation of optimized MRI CEST sequences |
Assessment of GlucoCEST effect of 3OMG on a number of tumour models including from breast tumour cell lines DA3, 4T1, and MCF7 and brain metastases of the DA3 tumour cells | 2019-03-28 | D4.3 Assessment of GlucoCEST effect of 3OMG on a number of tumour models.pdf |
Development and implementation of optimized MR T2 and T1ρ techniques | 2019-03-28 | D2.2 Development and implementation of optimized MR T2 and T1r techniques |
Technical validation of the GlucoCEST technique in human cancers | 2019-01-24 | D7.3 Technical validation of the GlucoCEST technique in human cancers.pdf |
Comparison of GlucoCEST contrast with 18F-FDG uptake | 2018-08-20 | D5.4 Comparison of GlucoCEST contrast with 18F-FDG uptake.pdf |
Assessment of in vivo pH dependence of GlucoCEST contrast in mouse tumour models using CEST-based agents | 2018-07-12 | D4.7 Assessment of in vivo pH dependence of GlucoCEST contrast in mouse tumour models using CEST-based agents.pdf |
GLINT Report Summary (1st Reporting Period) | 2018-01-24 | https://cordis.europa.eu/result/rcn/215096_en.html |
Ethics for scanning children and scanning of first paediatric lymphoma patient | 2018-01-18 | D7.8 Ethics for scanning children and scanning of first paediatric lymphoma patient.pdf |
pK by combined CEST 13C NMR spectroscopy | 2018-01-12 | D4.2 pK by combined CEST 13C NMR spectroscopy.pdf |
Assessing the intra-extracellular localization of 3OMG by measuring pH | 2017-03-08 | D4.1 Assessing the intra-extracellular localization of 3OMG by measuring pH.pdf |
Scanning of 1st adult patient for head-and-neck tumours and gliomas | 2017-03-02 | D7.7 Scanning of 1st adult patient for head-and-neck tumours and gliomas.pdf |
Assessment of intracellular energy substrate levels upon native and methylated glucose injections | 2017-02-15 | D4.4 Assessment of intracellular energy substrate levels upon native and methylated glucose injections.pdf |
Dependence of detection thresholds on administration ways | 2017-02-01 | D5.2 Dependence of detection thresholds on administration ways.pdf |
Ethics protocols, informed constens and information sheets for scanning the right number of patients | 2017-01-24 | D7.6 Ethics protocols informed consents and information sheets for scanning the right number of patients.pdf |
Estimate of the coefficients of variation, signal- and contrast-to-noise of both sequences in volunteers | 2017-01-10 | D7.2 Estimate of the coefficients of variation signal- and contrast-to-noise of both sequences in volunteers.pdf |
Up-to-date steady-state and dynamic MRI sequences for GlucoCEST | 2016-09-30 | D7.1 Up-to-date steady-state and dynamic MRI sequences for GlucoCEST.pdf |
Ethical approval for animal experiments, with personal licenses (incl. translation) | 2016-07-14 | D1.4 Ethical approval for animal experiments with personal licenses incl. translation |
N-pool Bloch-McConnell simulation software | 2016-06-30 | D2.1 N-pool Bloch-McConnell simulation software.pdf |
N-pool Bloch-McConnell simulation software: simulation with documentation | 2016-06-30 | http://www.cest-sources.org/doku.php |
N-pool Bloch-McConnell simulation software: download links to all packages | 2016-06-30 | https://github.com/cest-sources/BM_sim_fit |
Assessment of in vitro magnetic field dependence properties | 2016-06-30 | D5.1 Assessment of in vitro magnetic field dependence properties.pdf |
Set-up of website | 2016-04-29 | D1.3 Set-up of website.pdf |